Multi-cancer early-detection blood tests play a vital role in identifying potential signs of cancer at early stages. Detecting cancer at an early stage improves the chances of successful treatment leading to better outcomes. Early intervention may help prevent the spread of cancer to other parts of the body, reducing the need for aggressive treatments like surgery, chemotherapy, or radiation and the associated costs. Welcome to EasyCheck360®, a simple blood test that can detect as many as 30 types of common cancers.
EasyCheck360® – Multi-cancer test can detect cancers early that originate in the
Oral Cavity, Lungs, Breasts, Esophagus, Stomach, Liver, Pancreas,
Gallbladder, Kidney, Ovaries, Cervix, Prostate, and Bladder.
EasyCheck360® is the result of more than 10 years of intensive research by world renowned scientists and cancer experts. It has been clinically validated by analysis of more than 40,000 samples in large cohort studies which have established its accuracy.
Our representative will contact you and schedule the blood draw at your convenience.
No fasting is required.
Sample requirement: 20 mL whole blood.
Test results should be available within 12 business days after the sample is received at our facility.
The test report will be sent to your registered e-mail id.
Telemedicine is an online consultation service of Datar Cancer Genetics Private Limited using Whats App video/ audio call (“Tele-Consultation”) through its website.
You can use any of the payment modes mentioned below. You may also have a flexible payment schedule (EMI based).
We are a world-leading molecular oncology facility with a fully equipped laboratory, integrated process platforms, in-house bioinformatics team, and a huge genetic data base for precise and updated reporting. The facility is NABL, ISO, CAP and CLIA accredited. National and international cancer research institutes, and patients from all over the world including US, Switzerland, Germany and UK avail our services. We have developed breakthrough technologies for early detection of cancers and these tests are now available in Europe and the United States. With the help of latest technology and several years of extensive research, we offer highly effective treatment solutions to cancer patients for whom, multiple lines of treatment have failed.
* India Lab
Terms and Conditions
‘Datar Med-Assist’ is an online consultation service of Datar Cancer Genetics Private Limited using WhatsApp video/ audio call (“Tele-Consultation”) through its website. By accepting to avail of the Tele-Consultation Services (“Services”) of the Company, you agree to abide by the General Terms and Conditions defined by the Company and it is termed as your consent to proceed with Tele-Consultation with the Registered Medical Practitioner under the prevailing law. Further, you expressly agree that you will not use the Services of the Company if you do not understand or accept these Terms and Conditions including the General Terms and Conditions of the Company.
The services provided through the Website are not intended in any way to be a substitute for a face-to-face consultation with a doctor/physician. ‘Datar Med-Assist’ advise the users to make independent assessments in respect of its accuracy or usefulness and suitability prior to making any decision in reliance hereof. Terms ‘you’ and ‘your’ hereafter refers to the user, who is using/browsing through the Datar Med-Assist website easycheck360.com.
The terms and conditions herein form an agreement. Please read this agreement carefully and if you are not agreeable to any terms and conditions please do not proceed further.
By clicking on “I Agree” and proceeding further you signify that you read through, understood, and accepted the aforementioned terms and conditions of use of service. You must agree to the above terms and conditions in order to avail of the services through the website. If you have any queries or need any clarification or assistance please contact us at [email protected].